Stay updated on Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a significant number of study status updates and dates, while some location-related terms have been removed.
    Difference
    76%
    Check dated 2025-08-30T15:57:29.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T12:54:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, v2.16.11, with the previous version, v2.16.10, being removed. Additionally, a date of August 7, 2025, has been added.
    Difference
    0.6%
    Check dated 2025-08-09T08:08:30.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-02T04:15:10.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.8%
    Check dated 2025-07-26T01:04:15.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, v2.16.6, and the previous version, v2.16.5, has been removed. Additionally, a date of July 17, 2025, has been added.
    Difference
    0.6%
    Check dated 2025-07-18T22:10:19.000Z thumbnail image

Stay in the know with updates to Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Disitamab Vedotin & Pembrolizumab in HER2+ Urothelial Cancer Clinical Trial page.